KOLIBRI is an early-stage deep-tech biotech start-up backed by Entrepreneur First. Its aim is to unlock the potential of gene therapies and next-generation vaccines by rethinking the bioproduction of biologics, starting with viral vectors.
Viral vector manufacturing remains the blocking point to scale up and make gene therapies and viral vector-based vaccines more affordable and accessible.
To that end, KOLIBRI makes large-scale viral vector manufacturing 10x cheaper and 2x faster combining cutting edge techniques in chemical optimisation and acoustics.
STATION F Job board is always looking for great talent. Go ahead and send an application!